ResearcherJilin UniversityNo recent work listed
Yingjie Guo
Matched on ORCID iD 0009-0004-2529-4305; OpenAlex author ID A5113540769.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 8
2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper
Papers 6
- Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1. Co-author DOI 10.1002/jcp.27264↗
- CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation. Last author DOI 10.3892/or.2017.6168↗
- Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling. Co-author DOI 10.18632/oncotarget.21704↗
- Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2013.03.059↗
- Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. Co-author DOI 10.1371/journal.pone.0052095↗
- Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines. First author DOI 10.3892/mmr.2011.738↗
Closest collaborators
The 8 strongest of 8 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Min Liang · 2 shared papers, 2017–2018
- Paper CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleo… DOI 10.3892/or.2017.6168↗
- Paper Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, … DOI 10.18632/oncotarget.21704↗
- Limei Zhao · 2 shared papers, 2017–2019
- Paper Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1. DOI 10.1002/jcp.27264↗
- Paper Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, … DOI 10.18632/oncotarget.21704↗
- Jingkai Zhou · 2 shared papers, 2017–2019
- Paper Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1. DOI 10.1002/jcp.27264↗
- Paper Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, … DOI 10.18632/oncotarget.21704↗
- Yubin Ge · 2 shared papers, 2012–2013
- Paper Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cance… DOI 10.1016/j.bbrc.2013.03.059↗
- Paper Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. DOI 10.1371/journal.pone.0052095↗
- Zhixin Qiao · 1 shared paper, 2013
- Qun Yu · 1 shared paper, 2013
- Guan Wang · 1 shared paper, 2012
- Asfar Sohail Azmi · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.